Paperpal Prime Logo

Hereditary Cancer in Clinical Practice : Impact Factor & More

eISSN: 1897-4287pISSN: 1731-2302
JournalOpen Access

Key Metrics

CiteScore
3
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.85
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Hereditary Cancer in Clinical Practice

Hereditary Cancer in Clinical Practice Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2090 | USD 2490 | GBP 1790
Publication Time18
Editorial Review ProcessOpen peer review
General Details
LanguageEnglish
Society/Institute/SponsorInternational Hereditary Cancer Center; International Union Against Cancer
FrequencyContinuous publication
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 18
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessOpen peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Hereditary Cancer in Clinical Practice ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Hereditary Cancer in Clinical Practice

Barriers and facilitators of adherence to cancer prevention in Lynch Syndrome: an integrative review.
  • 17 Jul 2026
  • Hereditary cancer in clinical practice
The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer.
  • 15 Jul 2026
  • Hereditary cancer in clinical practice
BRCAShare: a video-based message can increase sharing of familial genetic test results.
  • 27 Jun 2026
  • Hereditary cancer in clinical practice
Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men.
  • 10 Jun 2026
  • Hereditary cancer in clinical practice
Are current Polish guidelines for prophylactic mastectomy sufficient?
  • 4 Jun 2026
  • Hereditary cancer in clinical practice
Renal cell carcinoma risk among individuals heterozygous for fumarate hydratase variants: further insights into genotype-phenotype correlations.
  • 12 May 2026
  • Hereditary cancer in clinical practice
Barriers and facilitators of adherence to cancer prevention in Lynch Syndrome: an integrative review.
  • 17 Jul 2026
  • Hereditary cancer in clinical practice
The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer.
  • 15 Jul 2026
  • Hereditary cancer in clinical practice
BRCAShare: a video-based message can increase sharing of familial genetic test results.
  • 27 Jun 2026
  • Hereditary cancer in clinical practice
Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men.
  • 10 Jun 2026
  • Hereditary cancer in clinical practice
Are current Polish guidelines for prophylactic mastectomy sufficient?
  • 4 Jun 2026
  • Hereditary cancer in clinical practice
Renal cell carcinoma risk among individuals heterozygous for fumarate hydratase variants: further insights into genotype-phenotype correlations.
  • 12 May 2026
  • Hereditary cancer in clinical practice

FAQs on Hereditary Cancer in Clinical Practice